Henrik Hansen
Direttore operativo presso ZENITH CAPITAL CORP.
Patrimonio netto: 140 272 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Henrik Hansen
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 10 | |
DTEC VENTURES
 DTEC VENTURES Investment ManagersFinance Dtec Ventures (Dtec Ventures) is a venture capital subsidiary of Dubai Silicon Oasis Authority founded in 2015. The firm is headquartered in Dubai, United Arab Emirates.
5
| Subsidiary | Investment Managers | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Henrik Hansen tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Sales & Marketing | |
| APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
| ONCOLYTICS BIOTECH INC. | Biotechnology | Chief Executive Officer | |
| RESVERLOGIX CORP. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO Chief Executive Officer Founder Chairman Director/Board Member | |
| E3 LITHIUM LIMITED | Chemicals: Specialty | Director/Board Member | |
Molecular Medicine BioServices, Inc.
 Molecular Medicine BioServices, Inc. Pharmaceuticals: MajorHealth Technology Molecular Medicine BioServices, Inc. is a company that provides services in the pharmaceutical industry. The company is based in Carlsbad, CA. The company has signed a manufacturing agreement with Cardium Therapeutics for the production of Generx and have expanded their services to better serve client vaccine development and testing needs. The company was acquired by Sigma-Aldrich Corp., part of Merck KGaA on November 19, 2015. | Pharmaceuticals: Major | Sales & Marketing | |
Vivaldi Biosciences, Inc.
 Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO. | Drugstore Chains | Director/Board Member | |
Reviva Pharmaceuticals, Inc.
 Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reviva Pharmaceuticals, Inc. operates as a clinical stage development pharmaceutical company. The firm develops various therapies using chemical genomics for treatment of central nervous system, cardiovascular, metabolic and inflammatory diseases. The company was founded by Laxminarayan Bhat in 2006 and is headquartered in Cupertino, CA. | Pharmaceuticals: Major | Director/Board Member | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Clarkson University | College/University | Masters Business Admin | |
| University of Alberta | College/University | Undergraduate Degree | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
| University of Western Ontario | College/University | Doctorate Degree | |
| University of Manitoba | College/University | Graduate Degree | |
| Technische Universität München | College/University | Doctorate Degree | |
| University of Calgary | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Detecon International GmbH
 Detecon International GmbH Miscellaneous Commercial ServicesCommercial Services Detecon International GmbH provides management consulting services. It advises telecommunications companies, governments, investors and regulatory authorities with solutions developed from the application of information and telecommunications technologies. The company was founded in 1977 and is headquartered in Cologne, Germany. | Miscellaneous Commercial Services | Consultant / Advisor | |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Hamburg | College/University | Undergraduate Degree | |
Mandarin Oriental Hotel Group
 Mandarin Oriental Hotel Group Hotels/Resorts/Cruise linesConsumer Services Part of Henderson Park Capital Partners UK LLP, Mandarin Oriental Hotel Group is a luxury hotel and resort operator with properties in 24 countries and territories. The company is based in New York, NY. The company's portfolio includes 35 hotels and seven residences, each reflecting the group's oriental heritage and unique sense of place. Mandarin Oriental has a strong pipeline of hotels and residences under development and is a member of the Jardine Matheson Group. Mandarin Oriental Hotel Group was acquired by Henderson Park Capital Partners UK LLP from Mandarin Oriental International Ltd. on September 14, 2022 for $139 million. | Hotels/Resorts/Cruise lines | Corporate Officer/Principal | |
| IMRIS INC. | Medical Specialties | Director of Finance/CFO | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Chairman | |
Haworth Ltd.
 Haworth Ltd. Office Equipment/SuppliesProducer Manufacturing Haworth Ltd. manufactures institutional furniture. The company was founded in 1977 and is headquartered in Toronto, Canada. | Office Equipment/Supplies | Corporate Officer/Principal | |
| IMV INC. | Biotechnology | Director/Board Member | |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Medical/Nursing Services | Director/Board Member | |
| Dubai Silicon Oasis Authority | General Government | Sales & Marketing Private Equity Investor | |
Cellastra, Inc.
 Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Biotechnology | Chairman | |
| Société Générale Corp. & Investment Banking (Capital Mkts) | Corporate Officer/Principal | ||
| University of the Philippines-Cebu | College/University | Undergraduate Degree | |
| NEOMA Business School | College/University | Graduate Degree | |
Lumendi Ltd.
 Lumendi Ltd. Medical SpecialtiesHealth Technology Lumendi Ltd. develops medical devices for the treatment of gastrointestinal conditions. The private company is based in Maidenhead, UK. The British company was founded in 2014 by Peter Johann. Peter Johann has been the CEO since 2014. | Medical Specialties | Chief Executive Officer | |
Kickshaw Ventures Ltd.
 Kickshaw Ventures Ltd. Financial ConglomeratesFinance Kickshaw Ventures Ltd. operates as a Canadian investment company. The private company is based in Calgary, Canada. Bradley George Thompson has been the CEO of the company since 2016. | Financial Conglomerates | Chief Executive Officer | |
| ENVERIC BIOSCIENCES, INC. | Pharmaceuticals: Other | Director/Board Member | |
| Wyvern Pharmaceuticals, Inc. | Chief Executive Officer | ||
| Avamab Pharma, Inc. | Chief Executive Officer | ||
| Università Bocconi | College/University | Graduate Degree | |
Vivaldi Biosciences AG
 Vivaldi Biosciences AG BiotechnologyHealth Technology Vivaldi Biosciences AG is a venture-backed company that focuses on research and development. It develops genetically engineered intranasal vaccines for epidemic and pandemic viral respiratory diseases. The company is headquartered in Vienna, Austria. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Canada | 20 |
| Stati Uniti | 13 |
| Germania | 7 |
| Svizzera | 4 |
| Francia | 3 |
Settori
| Health Technology | 23 |
| Consumer Services | 12 |
| Producer Manufacturing | 3 |
| Commercial Services | 3 |
| Process Industries | 2 |
Posizioni
| Director/Board Member | 69 |
| Corporate Officer/Principal | 29 |
| Independent Dir/Board Member | 24 |
| Chief Executive Officer | 16 |
| President | 16 |
Contatti più connessi
| Insiders | |
|---|---|
| Julie Cherrington | 32 |
| Eldon Smith | 29 |
| Peter Johann | 18 |
| Bradley Thompson | 17 |
| Kenneth Zuerblis | 12 |
| Sanjay Lakhotia | 10 |
| DANIEL REIS | 10 |
| Julien Plouzeau | 10 |
| Kelly McNeill | 8 |
| Anthony Cann | 7 |
| Mohammad Khoori | 5 |
| Donald McCaffrey | 4 |
| Essam Mohamed | 4 |
| Anna Karenina Marcos | 4 |
| Norman Wong | 3 |
- Borsa valori
- Insiders
- Henrik Hansen
- Connessioni Società
